Experts Clear the Air on the Disease and Treatment Burden of Chronic Rhinosinusitis with Nasal Polyps
For this article, EMJ interviewed Philippe Gevaert, who is a Professor in Rhinology and Allergy at the Department of Otorhinolaryngology in Ghent University, Belgium. Gevaert is a prominent figure in chronic rhinosinusitis and allergic rhinitis, having been involved in the European Rhinologic Society (ERS) and past-Chair of the ear, nose, throat (ENT) section of the European Academy of Allergy and Clinical Immunology (EAACI). In this interview, Gevaert explores the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) and shares his expert recommendations on streamlining their recognition and diagnosis, navigating the current unmet needs in patient and clinician education, as well as advocating for strengthened patient support systems. He stresses the importance of healthcare professionals working collaboratively to strategise and exchange best practices. Looking ahead, Gevaert expresses his optimism for the future of care and treatment for patients with CRSwNP.
Publication Details
- Journal
- EMJ Allergy & Immunology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.33590/emjallergyimmunol/epwf7628
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Regeneron Pharmaceuticals
- Argenx
- Genentech
- Sanofi Genzyme